Frontiers in Immunology | Cancer Immunity and Immunotherapy

Correction

Published on 16 Jul 2025

Corrigendum: Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient

in Cancer Immunity and Immunotherapy

Wenrui Wang
Wei Li
Tianqi Zhang
Zhenjing Jin
Lanlan Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1654196

116 views

Original Research

Published on 16 Jul 2025

Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whole-exome and transcriptomic profiling

in Cancer Immunity and Immunotherapy

Jing Zeng
Qingli Li
Kemin Li
Lu Yang
Lian Xu
Wei Wang
Kaixuan Yang
Qingbo Wei
Jin Wang
Changbin Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1605227

135 views

Original Research

Published on 16 Jul 2025

Systematic analysis of ZDHHC9 as a potential prognostic and immunotherapy biomarker in breast cancer

in Cancer Immunity and Immunotherapy

Desheng Zhou
Zhenpeng Wu
Yachao Cui
Doudou Wang
Hejun Song
Jun Chen
Hong Lin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1609621

172 views

Systematic Review

Published on 16 Jul 2025

Hepatic arterial infusion chemotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a meta-analysis of survival outcomes

in Cancer Immunity and Immunotherapy

Di Zeng
Zhimeng Cheng
Geng Liu
Jiong Lu
Bei Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1640970

158 views

Original Research

Published on 16 Jul 2025

Integrated multi-omics and machine learning reveal an immunogenic cell death-related signature for prognostic stratification and therapeutic optimization in colorectal cancer

in Cancer Immunity and Immunotherapy

Siyu Hou
Shanshan Heng
Shaozhuo Xie
Yuanchun Zhao
Jiajia Chen
Chunjiang Yu
Yuxin Lin
Xin Qi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1606874

251 views

Original Research

Published on 16 Jul 2025

Integrative spatial and single-cell transcriptomics elucidate programmed cell death-driven tumor microenvironment dynamics in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Kai Lei
Yutong Zhao
Shumin Li
Jiawei Liu
Wenhao Chen
Caihong Zhou
Yi Zhang
Jinmei Tan
Jian Wu
Qi Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1589563

170 views

Review

Published on 16 Jul 2025

Lymphoid stroma in all its states

in Cancer Immunity and Immunotherapy

Nicolas Barbier
Valentin Isen
Karin Tarte
David Roulois

Frontiers in Immunology

doi 10.3389/fimmu.2025.1633235

117 views

General Commentary

Published on 16 Jul 2025

Commentary: Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives

in Cancer Immunity and Immunotherapy

Nan Zhang
Wanqing Li
Haiyang Wu
Qiang Guo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1590342

175 views

Original Research

Published on 16 Jul 2025

The impact of sarcopenia on prognosis and fruquintinib efficacy in advanced colorectal cancer: a retrospective and mendelian randomization study

in Cancer Immunity and Immunotherapy

Yao Wang
Du Meilu
Shi Qi
Tang Yufei
Gao Song
Han Susu
Wen Haotian
Zhu Tingting
Wang Chao
Hou Fenggang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1582308

221 views

Original Research

Published on 16 Jul 2025

Identification of a stromal immunosuppressive barrier orchestrated by SPP1+/C1QC+ macrophages and CD8+ exhausted T cells driving gastric cancer immunotherapy resistance

in Cancer Immunity and Immunotherapy

Guichuang Ma
Xiaohan Liu
Qinrui Jiang
Shaowei Li
Qijing Wu
Bishan Liang
Fei Sun
Chunhui Gu
Wangjun Liao
Zhihua Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1618591

171 views

Mini Review

Published on 16 Jul 2025

Trigeminal nerve-driven neurogenic inflammation linking migraine to glioblastoma invasion: a literature review

in Cancer Immunity and Immunotherapy

Xiaoli Song
Qian Zhu
Jieying Zhang
Jin Yang
Xinxin Zhang
Qian Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1632154

274 views

Original Research

Published on 16 Jul 2025

Response gene to complement 32 promotes tumorigenesis by mediating DNA damage repair and inhibits CD8+ T cells infiltration in diffuse large B-cell lymphoma

in Cancer Immunity and Immunotherapy

Xiyuan Zhang
Tiange Lu
Chunlei Shi
Mengfei Ding
Ling Wang
Xinting Hu
Xin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1591615

178 views

Original Research

Accepted on 15 Jul 2025

Induction immunochemotherapy followed by definitive chemoradiotherapy and consolidation immunotherapy for unresectable stage Ⅲ non-small cell lung cancer: a multi-institutional retrospective cohort study

in Cancer Immunity and Immunotherapy

Zhixue Fu
Xin Dong
Jiawen Sun
Weihu Wang
Wei Deng
Yuting Zhao
Dan Yang
Leilei Jiang
Xiao Chang
Rong Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1602082

Review

Accepted on 15 Jul 2025

Chemokines: Humble yet Mighty Players in the Tumour Microenvironment

in Cancer Immunity and Immunotherapy

Suboj Babykutty
HIMA XAVIER
ATHIRA GIREESH G M
Juvin Ann Thomas
Priya Suboj
Arya S
Emmanuel Biju
Arya B
ROSHIN THOMAS DOMINIC

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601756

Original Research

Accepted on 15 Jul 2025

Risk factors and long-term prognostic impact of immunerelated pancreatic injury in patients receiving immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Yu Akazawa
Takuto Nosaka
Yosuke Murata
Tomoko Tanaka
Kazuto Takahashi
Tatsushi Naito
Masahiro Ohtani
Yasunari Nakamoto

Frontiers in Immunology

doi 10.3389/fimmu.2025.1590992

Original Research

Accepted on 15 Jul 2025

Combined single-cell RNA-seq and bulk RNA-seq construction of M2 TAMs signature for predicting HNSCC prognosis and immunotherapy

in Cancer Immunity and Immunotherapy

JiaLe Wang
Huan Li
Mingrui Shi
ChengHao Ren
Wu Wei
Qi Zhao
XinXin He
Zihui Yang
Jianhua Wei
Xinjie Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1620931